Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase theta-2 pseudogene (GSTT2P) is a duplicated, non-functional segment found near the functional GSTT2 gene in humans. Sequence analysis shows splice site abnormalities and a premature stop codon, preventing translation into a functional protein. GSTT2P shares sequence homology with other theta-class GSTs but has no known physiological or pathological roles, unlike the functional homologs which are involved in Phase II detoxification and potentially in carcinogenesis. GSTT2P (ENSG00000250470) is a pseudogene of the glutathione S-transferase theta family, and is not considered a therapeutic target. For valid GST theta targets, refer to GSTT1 or GSTT2.
Not applicable (GSTT2P does not produce a protein and has no known activity)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase theta-2 pseudogene (GSTT2P).